RANGAP1 and hydrops fetalis: In our study, the plasma levels of NUP153, IPO5, and RanGAP1 did not show a statistically significant difference between patients with advanced HF requiring MCS prior to HT and those who were clinically stable and underwent HT in an elective way, although NUP153 did demonstrate a trend toward significance (p = 0.07).